A. Leperre et al., COMPARED EFFECTS OF RUTHENIUM RED AND CIS [RU(NH3)(4)CL-2]CL ON THE ISOLATED ISCHEMIC-REPERFUSED RAT-HEART, Fundamental and clinical pharmacology, 9(6), 1995, pp. 545-553
The sequence ischaemia-reperfusion is characterized by reperfusion dam
age. The calcium overload occurring at the beginning of reperfusion is
one of the main mechanisms responsible for reperfusion damage. Ruthen
ium red, a blocker of the mitochondrial calcium uniport system, could
prevent this damage by preserving the ATP synthesis in the mitochondri
a. We tested ruthenium red and another ruthenium compound, cis-tetramm
ine dichlororuthenium (III) chloride in our experimental model of isch
aemic-reperfused rat hearts. After a 15 minute-stabilization period, t
he hearts were submitted to a 30 minute global ischaemia period and th
en reperfused for 45 minutes with the standard perfusion solution or w
ith ruthenium red or cis-tetrammine dichlororuthenium (III) chloride a
t 1, 3 or 9 mu M. Ruthenium red at 3 mu M exerted a protective effect
in our experimental conditions by showing a significant improvement of
the contractility recovery at the end of reperfusion and a significan
t decrease of the malondialdehyde production, which reflects free radi
cal production. The cis-tetrammine dichlororuthenium (III) chloride (c
ontaining 1 Ru ion per molecule) at 9 mu M was slighty less efficient
than ruthenium red at 3 mu M (containing 3 Ru ions per molecule). The
heart ruthenium binding was better for the ruthenium red than for the
cis-tetrammine dichlororuthenium (III) chloride, suggesting a role of
the ruthenium ion complexation in the crossing of the membrane, wherea
s the cardiac effect seemed to be linked to the ruthenium ion heart co
ncentration, which was similar for the ruthenium red at 3 mu M and for
the cis-tetrammine dichlororuthenium (III) chloride at 9 mu M. One ca
n hope that ruthenium compounds would limit reperfusion damage and inf
arct size after ischaemia in in vivo models.